Ciliopathies in Complex Congenital Heart Disease: Molecular Genetics, Embryologic Mechanisms and Clinical

Maria Felicia Gagliardi1,2, Emanuele Micaglio3, Angelo Micheletti2

  • 1Faculty of Medicine and Surgery, Milano-Bicocca University, 20126 Milan, Italy.

Genes
|May 27, 2026
PubMed

Insights

Ciliary dysfunction is linked to congenital heart defects (CHDs), explaining diverse phenotypes and aiding diagnosis. This review unifies understanding of cilia

Area of Science:

  • Developmental Biology
  • Genetics
  • Cell Biology

Background:

  • Congenital heart defects (CHDs) have established mechanisms, but complex syndromic contexts require early diagnosis.
  • Conotruncal defects often link to genetic syndromes like DiGeorge syndrome and RASopathies, involving shared cardiac outflow tract pathways.
  • A unifying framework is needed to connect ciliary dysfunction to CHD phenotypes.

Purpose of the Study:

  • To provide a unifying framework linking ciliary dysfunction to congenital heart defect (CHD) phenotypes.
  • To review the role of primary and motile cilia in cardiac morphogenesis and disease.
  • To explore signaling pathways regulated by cilia and their contribution to CHD.

Main Methods:

  • Integrative narrative review of genetic, experimental, and developmental studies.
  • Focus on the role of primary and motile cilia in cardiac development.
  • Analysis of cilia-regulated signaling pathways and their impact on disease phenotypes.

Main Results:

  • Primary and motile cilia are central regulators of cardiac development, integrating signals like morphogen gradients and mechanical cues.
  • Ciliary structure or signaling dysfunction contributes to complex CHD phenotypes, especially syndromic forms and laterality defects.
  • A cilia-centered model explains phenotypic heterogeneity in CHD and highlights shared mechanisms across conditions.

Conclusions:

  • Cilia-dependent mechanisms offer a unifying framework for understanding how genetic defects lead to disrupted cardiac morphogenesis.
  • This perspective can refine CHD interpretation and guide precision diagnostics.
  • It supports the development of pathway-informed therapeutic strategies for congenital heart defects.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...